AstraZeneca's Newly Occupied Alexion Hits Rock Bottom After Ultomiris (Ravulizumab) Fails to Show Efficacy in Patients with Amyotrophic Lateral Sclerosis AstraZeneca's 39 billion USD complete acqui...
Fecal Incontinence (FI) is a condition in which individuals lose the control of bowel movements leading to unexpected, involuntary leakage of stools. Also known as Bowel Incontinence, it is a result of constipation, diarrhea, and nerve damage due to aging. The condition can be of two types: urge incontinence, where...
Find MoreUNITY Biotechnology declares positive data from phase 1 clinical trial of UBX1325 in Advanced Vascular Eye Disease patients UNITY Biotechnology, Inc., a biotechnology company developing therapeutics to decrease, impede, or reverse diseases of aging, declared positive data from its Phase 1 safety study of U...
Find MoreWearables are electronic devices that are worn on the body part to track, analyze and transmit real-time personal data of the health or workout. The wearables come in different forms and sizes and some of the most common devices include a fitness tracker, headbands, posture monitors, wearable patches, smart glasses...
Find MoreInnoCare Receives Go-ahead for Clinical Trial of TYK2 Inhibitor ICP-332 in China InnoCare, a biopharma firm developing novel therapies for the treatment of cancer and autoimmune diseases, today announced the approval of Phase I clinical trial of its novel TYK2 (Tyrosine Kinase 2) inhibitor, ICP-332, by the China...
Find MoreOcugen-Bharat Biotech’s Covaxin Shows Efficacy Against B.1.617 Variant With the COVID-19 cases exponentially increasing, there is a worrisome climate all over the world. Physicians, doctors, researchers, the whole healthcare and pharmaceutical industry are at their toes fighting the second wave of the coronaviru...
Find MoreVertex leads in CRISPR Therapeutics partnership with USD 900 Million upfront Vertex has boosted a deal with CRISPR Therapeutics to USD 900 million upfront as the companies compete against bluebird bio to the market with a novel gene-editing therapy for sickle cell disease and beta-thalassemia called CTX001. B...
Find MoreCidara Therapeutics Inks USD 780M Deal with J&J The share price of Cidara observed a sudden jump after the news of the collaboration of the company with J&J came. Cidara Therapeutics has announced a deal with Johnson & Johnson to develop and commercialize Cidara’s candidate CD388 to prevent and treat...
Find MoreChimeric Antigen Receptor (CAR) Therapies have changed the treatment paradigm of hematological malignancies to a vast extent. These personalized therapies have not only evolved as a game-changer in the field of medicine but also in the lives of the patients. Until the last approvals made by Novartis and Kite Pha...
Find MoreAmgen to acquire Rodeo Therapeutics for USD 55 Million Upfront Amgen Inc. and Rodeo Therapeutics Corporation announced a deal under which Amgen will take over Rodeo, a privately-held biopharmaceutical company based in Seattle, which develops small-molecule therapies to enhance regeneration and repair of se...
Find MorePeanut Allergy accounts for the majority of severe food-associated allergic reactions. It is strictl.....
Find MoreInteroperability refers to the ability of electronic health records (EHRs) and other healthcare data.....
Find MoreSpinal Cord Injury (SCI) causes extreme back pain and at times triggers an “accelerating aging” .....
Find MoreGout is a chronic disease caused by the deposition of monosodium urate (MSU) crystals in joints. It .....
Find MoreWearable technology has been gaining momentum for the last few years as an effect of the fourth indu.....
Find MoreIn the present scenario, the 3-D printing and bioprinting technology in the medical devices industry.....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.